Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6989)
All Articles published online
|
Publishing Process of This Article
|
Oct 27, 2013 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zampino R, Marrone A, Restivo L, Guerrera B, Sellitto A, Rinaldi L, Romano C, Adinolfi LE. Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. World J Hepatol 2013; 5(10): 528-540 [PMID: 24179612 DOI: 10.4254/wjh.v5.i10.528] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v5/i10/528.htm |
| Number | Citing Articles |
| 1 |
Syed Yasir Abbas, Hafsa Auroj, Arshad Sattar Lakho, Akbar Gohar Abro, Ghulam Shahar Bano, Tahir Hanif Rajput. Frequency Of Peripheral Neuropathy in Chronic Hepatitis C Patients Presenting at Liaquat University Hospital, Hyderabad. Pakistan BioMedical Journal 2022; : 263 doi: 10.54393/pbmj.v5i5.473
|
| 2 |
O.O. Olubamwo, A.O. Aregbesola, J. Miettola, J. Kauhanen, T.-P. Tuomainen. Hepatitis C and risk of coronary atherosclerosis – A systematic review. Public Health 2016; 138: 12 doi: 10.1016/j.puhe.2016.04.005
|
| 3 |
Shari S. Rogal, Klaus Bielefeldt, Ajay D. Wasan, Eva Szigethy, Francis Lotrich, Andrea F. DiMartini. Fibromyalgia Symptoms and Cirrhosis. Digestive Diseases and Sciences 2015; 60(5): 1482 doi: 10.1007/s10620-014-3453-3
|
| 4 |
Ida Fortini, Eustáquio Martins Gomes Arouca, Fatima Mitiko Tengam, Ricardo Nitrini. Chronic HCV infection and neuropsychiatric dysfunction. eNeurologicalSci 2019; 17: 100206 doi: 10.1016/j.ensci.2019.100206
|
| 5 |
Takashi Kumada, Hidenori Toyoda, Satoshi Yasuda, Toshifumi Tada, Takanori Ito, Junko Tanaka. Long‐term outcomes of viral eradication in patients with hepatitis C virus infection and mild hepatic fibrosis. Journal of Viral Hepatitis 2021; 28(9): 1293 doi: 10.1111/jvh.13562
|
| 6 |
Tangui Barré, Marie Libérée Nishimwe, Camelia Protopopescu, Fabienne Marcellin, Fabrice Carrat, Céline Dorival, Elisabeth Delarocque‐Astagneau, Dominique Larrey, Marc Bourlière, Ventzislava Petrov‐Sanchez, Mélanie Simony, Stanislas Pol, Hélène Fontaine, Patrizia Carrieri. Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C‐infected patients (ANRS CO22 Hepather cohort). Journal of Viral Hepatitis 2020; 27(12): 1473 doi: 10.1111/jvh.13380
|
| 7 |
O. V. Masalova, E. I. Lesnova, E. I. Samokhvalov, K. Yu. Permyakova, A. V. Ivanov, S. N. Kochetkov, A. A. Kushch. Low-molecular-weight regulators of biogenic polyamine metabolism affect cytokine production and expression of hepatitis С virus proteins in Huh7.5 human hepatocarcinoma cells. Molecular Biology 2017; 51(3): 453 doi: 10.1134/S0026893317030128
|
| 8 |
Syeda Zainab Ilyas, Rabia Tabassum, Haroon Hamed, Shafiq Ur Rehman, Ishtiaq Qadri. Hepatitis C Virus-Associated Extrahepatic Manifestations in Lung and Heart and Antiviral Therapy-Related Cardiopulmonary Toxicity. Viral Immunology 2017; 30(9): 633 doi: 10.1089/vim.2017.0009
|
| 9 |
Pasquale Ambrosino, Luciano Tarantino, Giovanni Di Minno, Mariano Paternoster, Vincenzo Graziano, Maurizio Petitto, Aurelio Nasto, Matteo Nicola Di Minno. The risk of venous thromboembolism in patients with cirrhosis. Thrombosis and Haemostasis 2017; 117(01): 139 doi: 10.1160/TH16-06-0450
|
| 10 |
Chunlin Jiang, Jianting Long, Baoxian Liu, Xiaoyan Xie, Ming Kuang. Mcl-1 Is a Novel Target of miR-26b That Is Associated with the Apoptosis Induced by TRAIL in HCC Cells. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/572738
|
| 11 |
Hanqing Chen. Iron metabolism in non-alcoholic fatty liver disease: A promising therapeutic target. Liver Research 2022; 6(4): 203 doi: 10.1016/j.livres.2022.09.003
|
| 12 |
Annalisa Cespiati, Marica Meroni, Rosa Lombardi, Giovanna Oberti, Paola Dongiovanni, Anna Ludovica Fracanzani. Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies. Biomedicines 2022; 10(1): 182 doi: 10.3390/biomedicines10010182
|
| 13 |
Matías Gómez, Emiliano Gentile, M. Martini, María Cuestas, Verónica Mathet, Graciela Moltrasio, Albertina Moglioni. Synthesis of New Indanyl Nucleoside Analogues and their Biological Evaluation on Hepatitis C Virus (HCV) Replicon. Molecules 2019; 24(5): 990 doi: 10.3390/molecules24050990
|
| 14 |
Katharina Büsch, Jesper Waldenström, Martin Lagging, Soo Aleman, Ola Weiland, Jan Kövamees, Ann-Sofi Duberg, Jonas Söderholm. Prevalence and comorbidities of chronic hepatitis C: a nationwide population-based register study in Sweden. Scandinavian Journal of Gastroenterology 2017; 52(1): 61 doi: 10.1080/00365521.2016.1228119
|
| 15 |
Luigi Elio Adinolfi, Riccardo Nevola, Luca Rinaldi, Ciro Romano, Mauro Giordano. Chronic Hepatitis C Virus Infection and Depression. Clinics in Liver Disease 2017; 21(3): 517 doi: 10.1016/j.cld.2017.03.007
|
| 16 |
Zobair M Younossi, Maria Stepanova, Tarik Asselah, Graham Foster, Keyur Patel, Norbert Bräu, Mark Swain, Tram Tran, Rafael Esteban, Massimo Colombo, Stephen Pianko, Linda Henry, Marc Bourliere. Hepatitis C in Patients With Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes. Clinical Infectious Diseases 2018; 66(11): 1742 doi: 10.1093/cid/cix1106
|
| 17 |
Chester J. Donnally, Parthik D. Patel, Jose A. Canseco, Kartik Shenoy, Srikanth N. Divi, Vadim Goz, Abdul R. Arain, Alexander R. Vaccaro. Hepatitis C Virus Infection as a Predictor of Complications and Increased Costs Following Primary Lumbar Fusion Surgery. Spine 2020; 45(16): E1020 doi: 10.1097/BRS.0000000000003481
|
| 18 |
Theodoros Androutsakos, Dimitrios Mouziouras, Stamatia Katelani, Mina Psichogiou, Petros P. Sfikakis, Athanase D. Protogerou, Antonios A. Argyris. A Comparative Study on the Presence and Reversibility of Subclinical Arterial Damage in HCV-Infected Individuals and Matched Controls. Viruses 2023; 15(6): 1374 doi: 10.3390/v15061374
|
| 19 |
Vivek Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, Pankti Balar, Avinash Khadela, Dixa Vaghela, Shruti Soni, Charles R. Ashby, Amit K. Tiwari. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes. Cancer Reports 2023; 6(S1) doi: 10.1002/cnr2.1821
|
| 20 |
Stephanie Chan, Jing-hsiung Ou. Hepatitis C Virus-Induced Autophagy and Host Innate Immune Response. Viruses 2017; 9(8): 224 doi: 10.3390/v9080224
|
| 21 |
Hyun Min Kim, Yong-ho Lee, Kyungdo Han, Byung-Wan Lee, Eun Seok Kang, Jaetaek Kim, Bong-Soo Cha. Impact of diabetes mellitus and chronic liver disease on the incidence of dementia and all-cause mortality among patients with dementia. Medicine 2017; 96(47): e8753 doi: 10.1097/MD.0000000000008753
|
| 22 |
Anna Chudnovets, Jin Liu, Harish Narasimhan, Yang Liu, Irina Burd, Sabra Klein. Role of Inflammation in Virus Pathogenesis during Pregnancy. Journal of Virology 2020; 95(2) doi: 10.1128/JVI.01381-19
|
| 23 |
Hrvoje Roguljic, Vjera Nincevic, Kristina Bojanic, Lucija Kuna, Robert Smolic, Aleksandar Vcev, Dragan Primorac, Andrijana Vceva, George Y. Wu, Martina Smolic. Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.678546
|
| 24 |
Ragunath Singaravelu, Rodney S Russell, D Lorne Tyrrell, John Paul Pezacki. Hepatitis C virus and microRNAs: miRed in a host of possibilities. Current Opinion in Virology 2014; 7: 1 doi: 10.1016/j.coviro.2014.03.004
|
| 25 |
Alessandra Rodrigues de Camargo, Jefferson Rocha Tenório, Fabiana Martins, Liliane Janete Grando, Esther Buzaglo Dantas Corrêa, Marília Trierveiler, Karem L. Ortega. Subset of CD8+ and FOXP3 + T cells in lichen planus associated with chronic hepatitis C infection. Oral Diseases 2019; 25(4): 1100 doi: 10.1111/odi.13069
|
| 26 |
Michael Broker, Shalom Z. Frager, Nayan S. Patel, Edward Lebovics, William H. Frishman. The Inflammatory Relationship Between Hepatitis C Virus With Coronary and Carotid Atherosclerosis. Cardiology in Review 2021; 29(4): 178 doi: 10.1097/CRD.0000000000000314
|
| 27 |
Hemalatha Mani, Jui-Hung Yen, Hao-Jen Hsu, Chun-Chun Chang, Je-Wen Liou. Hepatitis C virus core protein: Not just a nucleocapsid building block, but an immunity and inflammation modulator. Tzu Chi Medical Journal 2022; 34(2): 139 doi: 10.4103/tcmj.tcmj_97_21
|
| 28 |
Jonas Söderholm, Charlotta Millbourn, Katharina Büsch, Jan Kövamees, Robert Schvarcz, Karin Lindahl, Annette Bruchfeld. Higher risk of renal disease in chronic hepatitis C patients: Antiviral therapy survival benefit in patients on hemodialysis. Journal of Hepatology 2018; 68(5): 904 doi: 10.1016/j.jhep.2017.12.003
|
| 29 |
Thomas A. Verbeek, Jonathan G. Stine, Fuat H. Saner, Dmitri Bezinover. Hypercoagulability in End-stage Liver Disease: Review of Epidemiology, Etiology, and Management. Transplantation Direct 2018; 4(11): e403 doi: 10.1097/TXD.0000000000000843
|
| 30 |
Pedro Molina-Sánchez, Amaia Lujambio. Hepatocellular Carcinoma. Molecular and Translational Medicine 2019; : 333 doi: 10.1007/978-3-030-21540-8_16
|
| 31 |
E Rosenthal, P Cacoub. Extrahepatic manifestations in chronic hepatitis C virus carriers. Lupus 2015; 24(4-5): 469 doi: 10.1177/0961203314556140
|
| 32 |
Nancy Reau, Francis Vekeman, Eric Wu, Yanjun Bao, Yuri Sanchez Gonzalez. Prevalence and economic burden of extrahepatic manifestations of hepatitis C virus are underestimated but can be improved with therapy. Hepatology Communications 2017; 1(5): 439 doi: 10.1002/hep4.1049
|
| 33 |
Luigi Elio Adinolfi, Luca Rinaldi, Riccardo Nevola. Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments?. World Journal of Gastroenterology 2018; 24(41): 4617-4621 doi: 10.3748/wjg.v24.i41.4617
|
| 34 |
Zakaria Boulahtouf, Alessia Virzì, Thomas F. Baumert, Eloi R. Verrier, Joachim Lupberger. Signaling Induced by Chronic Viral Hepatitis: Dependence and Consequences. International Journal of Molecular Sciences 2022; 23(5): 2787 doi: 10.3390/ijms23052787
|
| 35 |
Alicja E. Grzegorzewska, Adrianna Mostowska, Wojciech Warchoł, Paweł P. Jagodziński. Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case–control study. BMC Infectious Diseases 2021; 21(1) doi: 10.1186/s12879-021-06597-4
|
| 36 |
Alessia Virzì, Armando Roca Suarez, Thomas Baumert, Joachim Lupberger. Oncogenic Signaling Induced by HCV Infection. Viruses 2018; 10(10): 538 doi: 10.3390/v10100538
|
| 37 |
Hans-Peter Kapfhammer. Depression, Angst, traumatischer Stress und internistische Erkrankungen. 2022; : 475 doi: 10.1007/978-3-662-65873-4_7
|
| 38 |
Michele Nardone, Dario Di Stasio, Alberta Lucchese, Daniele Gentili, Giulia Cattabianchi, Carlo Signorelli, Pierangelo Sarchi, Giovanna Pulcrano, Valentino Lembo, Paola Maria Pirola, Dorina Lauritano, Francesco Carinci. Hepatitis C Epidemiology: Insights from a Comprehensive Cohort Study in ASST Melegnano and Martesana, Lombardia Region, Northern Italy. Pathogens 2024; 13(3): 215 doi: 10.3390/pathogens13030215
|
| 39 |
Dean L. Winslow. Hepatitis C virus infection and cardiac dysfunction in women. AIDS 2021; 35(10): 1689 doi: 10.1097/QAD.0000000000002938
|
| 40 |
M. Jadoul, A.A. Awan, M.C. Berenguer, A. Bruchfeld, F. Fabrizi, D.S. Goldberg, J. Jia, N. Kamar, R. Mohamed, M.G. Pessôa, S. Pol, M.E. Sise, P. Martin. KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney International 2022; 102(6): S129 doi: 10.1016/j.kint.2022.07.013
|
| 41 |
Marina Serper. Direct acting antivirals for patients without advanced liver disease: All for treatment and treatment for all?. Hepatology 2018; 68(3): 804 doi: 10.1002/hep.29873
|
| 42 |
Donald D Anthony, Mark S Sulkowski, Laura M Smeaton, Sofi Damjanovska, Carey L Shive, Corinne M Kowal, Daniel E Cohen, Debika Bhattacharya, Beverly L Alston-Smith, Ashwin Balagopal, David L Wyles. Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus–HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation. The Journal of Infectious Diseases 2020; 222(8): 1334 doi: 10.1093/infdis/jiaa254
|
| 43 |
Ming-Shyan Lin, Chang-Min Chung, Ming-Ling Chang, Mei-Yen Chen, Shih-Tai Chang, Pao-Hsien Chu, Tien-Hsing Chen, Wey-Yil Lin, Tung-Jung Huang, Yu-Sheng Lin. The Unraveled Link Between Antiviral Therapy and Heart Failure Hospitalization in Chronic Hepatitis C Virus Infection ― A Nationwide Cohort Study ―. Circulation Journal 2018; 82(6): 1623 doi: 10.1253/circj.CJ-17-1118
|
| 44 |
Daniel J. Ruzicka, Jumpei Tetsuka, Go Fujimoto, Tatsuya Kanto. Comorbidities and co-medications in populations with and without chronic hepatitis C virus infection in Japan between 2015 and 2016. BMC Infectious Diseases 2018; 18(1) doi: 10.1186/s12879-018-3148-z
|
| 45 |
Vukica Đorđević, Dobrila Stanković Đorđević, Branislava Kocić, Marina Dinić, Danka Sokolović, Jana Pešić Stanković, Daniele Vergara. The Impact of Hepatitis C Virus Genotypes on Oxidative Stress Markers and Catalase Activity. Oxidative Medicine and Cellular Longevity 2021; 2021: 1 doi: 10.1155/2021/6676057
|
| 46 |
Lucio Boglione, Tommaso Lupia, Giuseppe Cariti, Giovanni Di Perri. Efficacy and safety of interferon-free regimens in patients affected by chronic hepatitis C and psychiatric disorders. Journal of Infection and Chemotherapy 2020; 26(1): 18 doi: 10.1016/j.jiac.2019.06.004
|
| 47 |
Lucia Flores-Contreras, Ana S Sandoval-Rodríguez, Mayra G Mena-Enriquez, Silvia Lucano-Landeros, Inmaculada Arellano-Olivera, Arnulfo Álvarez-Álvarez, M Guadalupe Sanchez-Parada, Juan Armendáriz-Borunda. Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C. BMC Gastroenterology 2014; 14(1) doi: 10.1186/1471-230X-14-131
|
| 48 |
Hiba Sami, Safiya Firoze, Parvez A. Khan. Viral and Fungal Infections of the Central Nervous System: A Microbiological Perspective. 2023; : 205 doi: 10.1007/978-981-99-6445-1_11
|
| 49 |
Harleen K. Dyal, Maria Aguilar, Taft Bhuket, Benny Liu, Edward W. Holt, Sharon Torres, Ramsey Cheung, Robert J. Wong. Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review. Digestive Diseases and Sciences 2015; 60(9): 2813 doi: 10.1007/s10620-015-3760-3
|
| 50 |
T. Revuelto Artigas, N. Zaragoza Velasco, X. Gómez Arbones, T. Vidal Ballester, C. Piñol Felis, J.M. Reñe Espinet, A. Betriu Bars. Chronic hepatitis C infection: An independent risk factor for subclinical atheromatosis. Revista Clínica Española (English Edition) 2019; 219(6): 293 doi: 10.1016/j.rceng.2019.02.008
|
| 51 |
Pasquale Ambrosino, Roberta Lupoli, Alessandro Di Minno, Luciano Tarantino, Gaia Spadarella, Paolo Tarantino, Aurelio Nasto, Aldo Celentano, Matteo Nicola Dario Di Minno. The risk of coronary artery disease and cerebrovascular disease in patients with hepatitis C: A systematic review and meta-analysis. International Journal of Cardiology 2016; 221: 746 doi: 10.1016/j.ijcard.2016.06.337
|
| 52 |
Chang Ho Lee, Ji Hyun Kim, Seong-Wook Lee. The role of microRNAs in Hepatitis C Virus replication and related liver diseases. Journal of Microbiology 2014; 52(6): 445 doi: 10.1007/s12275-014-4267-x
|
| 53 |
Akinori Uruha, Satoru Noguchi, Yukiko K. Hayashi, Rie S. Tsuburaya, Takahiro Yonekawa, Ikuya Nonaka, Ichizo Nishino. Hepatitis C virus infection in inclusion body myositis. Neurology 2016; 86(3): 211 doi: 10.1212/WNL.0000000000002291
|
| 54 |
Pasquale Ambrosino, Luciano Tarantino, Livio Criscuolo, Aurelio Nasto, Aldo Celentano, Matteo Nicola Di Minno. The risk of venous thromboembolism in patients with hepatitis C. Thrombosis and Haemostasis 2016; 116(11): 958 doi: 10.1160/TH16-03-0185
|
| 55 |
Tamara Revuelto Artigas, Àngels Betriu Bars, Natividad Zaragoza Velasco, Xavier Gómez Arbones, Teresa Vidal Ballester, Carme Piñol Felis, Josep Maria Reñé Espinet. Antiviral treatment does not improve subclinical atheromatosis in patients with chronic hepatitis caused by hepatitis C virus. Gastroenterología y Hepatología (English Edition) 2019; 42(6): 362 doi: 10.1016/j.gastre.2019.02.031
|
| 56 |
Benli Jia, Dongsheng Yu, Gang Yu, Yunsheng Cheng, Yang Wang, Xiaoqiang Yi, Xiaoping Li, Yong Wang. Naringenin improve hepatitis C virus infection induced insulin resistance by increase PTEN expression via p53-dependent manner. Biomedicine & Pharmacotherapy 2018; 103: 746 doi: 10.1016/j.biopha.2018.04.110
|
| 57 |
Javier Ampuero, Manuel Romero-Gómez. Assessing cardiovascular risk in hepatitis C: An unmet need. World Journal of Hepatology 2015; 7(19): 2214-2219 doi: 10.4254/wjh.v7.i19.2214
|
| 58 |
Maria Mazzitelli, Carlo Torti, Jolanda Sabatino, Greta Luana D’Ascoli, Chiara Costa, Vincenzo Pisani, Elena Raffetti, Salvatore De Rosa, Alessio Strazzulla, Alfredo Focà, Maria Carla Liberto, Ciro Indolfi. Evaluation of cardiac function by global longitudinal strain before and after treatment with sofosbuvir-based regimens in HCV infected patients. BMC Infectious Diseases 2018; 18(1) doi: 10.1186/s12879-018-3426-9
|
| 59 |
Kiyotaka Yamazaki, Dendy Macaulay, Yan Song, Yuri Sanchez Gonzalez. Clinical and Economic Burden of Patients with Chronic Hepatitis C with Versus Without Antiviral Treatment in Japan: An Observational Cohort Study Using Hospital Claims Data. Infectious Diseases and Therapy 2019; 8(2): 285 doi: 10.1007/s40121-019-0234-5
|
| 60 |
Evgeniya V. Shmeleva, Francesco Colucci. Maternal natural killer cells at the intersection between reproduction and mucosal immunity. Mucosal Immunology 2021; 14(5): 991 doi: 10.1038/s41385-020-00374-3
|
| 61 |
Nobukazu Ishizaka, Yuko Ishizaka, Minoru Yamkado. Atherosclerosis as a Possible Extrahepatic Manifestation of Chronic Hepatitis C Virus Infection. Clinical Medicine Insights: Cardiology 2014; : CMC.S17069 doi: 10.4137/CMC.S17069
|
| 62 |
Clodoveo Ferri, Manuel Ramos-Casals, Anna Linda Zignego, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, David Saadoun, Anne Claire Desbois, Marco Sebastiani, Milvia Casato, Peter Lamprecht, Alessandra Mangia, Athanasios G Tzioufas, Zobair M Younossi, Patrice Cacoub. International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement. Autoimmunity Reviews 2016; 15(12): 1145 doi: 10.1016/j.autrev.2016.09.006
|
| 63 |
Vinicius Nunes Cordeiro Leal, Edione Cristina Reis, Alessandra Pontillo. Inflammasome in HIV infection: Lights and shadows. Molecular Immunology 2020; 118: 9 doi: 10.1016/j.molimm.2019.12.001
|
| 64 |
Letitia Toma, Mihai Dodot, Anca Zgura, Nicolae Bacalbasa, Andrei Silaghi, Razvan Simu, Teodora Isac, Adriana Mercan-Stanciu. Calprotectin in viral systemic infections—COVID-19 versus hepatitis C virus. Clinical and Experimental Medicine 2022; 22(2): 311 doi: 10.1007/s10238-021-00743-7
|
| 65 |
Yuan Liu, Li Chen, Ziying Zou, Bing Zhu, Zonghai Hu, Ping Zeng, Lijuan Wu, Jie Xiong. Hepatitis C virus infection induces elevation of CXCL10 in human brain microvascular endothelial cells. Journal of Medical Virology 2016; 88(9): 1596 doi: 10.1002/jmv.24504
|
| 66 |
Joshua S Davis, Melissa Young, Sandra Lennox, Tracey Jones, Kim Piera, Robert Pickles, Stephen Oakley. The effect of curing hepatitis C with direct-acting antiviral treatment on endothelial function. Antiviral Therapy 2018; 23(8): 687 doi: 10.3851/IMP3257
|
| 67 |
Marianna Sallustro, Aldo Marrone, Anna Florio. A Case Report on Treatment of Nonhealing Leg Ulcer: Do Not Forget the Underlying Disease. The International Journal of Lower Extremity Wounds 2023; 22(1): 190 doi: 10.1177/1534734621999029
|
| 68 |
Tung Huynh, Johnathan Zhang, Ke-Qin Hu. Hepatitis C Virus Clearance by Direct-acting Antiviral Results in Rapid Resolution of Hepatocytic Injury as Indicated by Both Alanine Aminotransferase and Aspartate Aminotransferase Normalization. Journal of Clinical and Translational Hepatology 2018; 6(3): 1 doi: 10.14218/JCTH.2018.00014
|
| 69 |
Nour Beydoun, Matthew J. Feinstein. Heart Failure in Chronic Infectious and Inflammatory Conditions: Mechanistic Insights from Clinical Heterogeneity. Current Heart Failure Reports 2022; 19(5): 267 doi: 10.1007/s11897-022-00560-3
|
| 70 |
Ahmed Akhter, Adnan Said. Cutaneous Manifestations of Viral Hepatitis. Current Infectious Disease Reports 2015; 17(2) doi: 10.1007/s11908-014-0452-7
|
| 71 |
O. V. Masalova, E. I. Lesnova, K. Yu. Permyakova, E. I. Samokhvalov, A. V. Ivanov, S. N. Kochetkov, A. A. Kushch. Effect of Hepatitis C virus proteins on the production of proinflammatory and profibrotic cytokines in Huh7.5 human hepatoma cells. Molecular Biology 2016; 50(3): 422 doi: 10.1134/S0026893316020163
|
| 72 |
Mohamed A. Abd El Hafez, Zeinab Abdel Aziz Kasemy. Effect of direct-acting antivirals on platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with hepatitis C virus-related thrombocytopenia. The Egyptian Journal of Internal Medicine 2019; 31(3): 296 doi: 10.4103/ejim.ejim_14_19
|
| 73 |
Rei-Yeuh Chang, Sheri Hsueh-Hua Ho, Han-Lin Tsai, Malcolm Koo. Association of anxiety and depression with chronic liver diseases in patients with noncardiac chest pain: A cross-sectional study. Medicine 2022; 101(31): e29620 doi: 10.1097/MD.0000000000029620
|
| 74 |
|
| 75 |
Javier A. Pagan, Marco Ladino, David Roth. End-Stage Renal Disease and Treatment of Hepatitis C Virus Infection. Current Hepatology Reports 2018; 17(1): 78 doi: 10.1007/s11901-018-0387-9
|
| 76 |
Tram T. Tran, Darshan Mehta, Federico Mensa, Caroline Park, Yanjun Bao, Yuri Sanchez Gonzalez. Pan-Genotypic Hepatitis C Treatment with Glecaprevir and Pibrentasvir for 8 Weeks Resulted in Improved Cardiovascular and Metabolic Outcomes and Stable Renal Function: A Post-Hoc Analysis of Phase 3 Clinical Trials. Infectious Diseases and Therapy 2018; 7(4): 473 doi: 10.1007/s40121-018-0218-x
|
| 77 |
Tamara Revuelto Artigas, Àngels Betriu Bars, Natividad Zaragoza Velasco, Xavier Gómez Arbones, Teresa Vidal Ballester, Carme Piñol Felis, Josep Maria Reñé Espinet. El tratamiento antiviral no mejora la ateromatosis subclínica en pacientes con hepatitis crónica por virus de la hepatitis C. Gastroenterología y Hepatología 2019; 42(6): 362 doi: 10.1016/j.gastrohep.2019.02.002
|
| 78 |
Beatriz Álvarez, Clara Restrepo, Marcial García, María A. Navarrete-Muñoz, María A. Jiménez-Sousa, Laura Prieto, Alfonso Cabello, Sara Nistal, Salvador Resino, Miguel Górgolas, Norma Rallón, José M. Benito. Liver Stiffness Hinders Normalization of Systemic Inflammation and Endothelial Activation after Hepatitis C Virus (HCV) Eradication in HIV/HCV Coinfected Patients. Vaccines 2020; 8(2): 323 doi: 10.3390/vaccines8020323
|
| 79 |
Takanobu Iwadare, Takefumi Kimura, Naoki Tanaka, Tomoo Yamazaki, Shun-ichi Wakabayashi, Taiki Okumura, Hiroyuki Kobayashi, Yuki Yamashita, Sai P. Pydi, Tomoyuki Nakajima, Mai Iwaya, Ayumi Sugiura, Satoru Joshita, Takeshi Uehara, Takeji Umemura. Circulating thrombospondin 2 levels reflect fibrosis severity and disease activity in HCV-infected patients. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-23357-9
|
| 80 |
Silvana Zito, Simona Mercurio, Giuseppe Mercurio, Alessandro Pigoni, Gian Mario Mandolini, Elisabetta Caletti. Neurocognitive impairment and cerebral metabolic alterations induced by direct hepatitis C virus neuroinvasion: implications on quality of life. Minerva Psichiatrica 2019; 60(2) doi: 10.23736/S0391-1772.19.02012-0
|
| 81 |
Tangui Barré, Teresa Rojas Rojas, Karine Lacombe, Camelia Protopopescu, Isabelle Poizot-Martin, Marie Libérée Nishimwe, David Zucman, Laure Esterle, Eric Billaud, Hugues Aumaitre, Olivier Bouchaud, David Rey, Lionel Piroth, Dominique Salmon-Ceron, Linda Wittkop, Philippe Sogni, Maria Patrizia Carrieri, Lawrence Serfaty, Fabienne Marcellin. Cannabis use and reduced risk of elevated fatty liver index in HIV-HCV co-infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH). Expert Review of Anti-infective Therapy 2021; 19(9): 1147 doi: 10.1080/14787210.2021.1884545
|
| 82 |
Alaa Badawi, Giancarlo Di Giuseppe, Paul Arora, Hans Tillmann. Cardiovascular disease risk in patients with hepatitis C infection: Results from two general population health surveys in Canada and the United States (2007-2017). PLOS ONE 2018; 13(12): e0208839 doi: 10.1371/journal.pone.0208839
|
| 83 |
Sara C. LaHue, Dolores Torres, Nicole Rosendale, Vineeta Singh. Stroke Characteristics, Risk Factors, and Outcomes in Transgender Adults. The Neurologist 2019; 24(2): 66 doi: 10.1097/NRL.0000000000000226
|
| 84 |
G. N. Khokhlova, O. V. Koltsova, E. R. Isaeva, E. V. Boeva, V. V. Rassokhin. Cognitive training as a technology for protecting and restoring the functions of the central nervous system in patients with infectious pathology. HIV Infection and Immunosuppressive Disorders 2023; 15(2): 19 doi: 10.22328/2077-9828-2023-15-2-19-36
|
| 85 |
Sandra J. Page, Maria M. Rivera, David E. Kleiner, Xiongce Zhao, Sungyoung Auh, Elaine F. Remmers, Theo Heller. Three variants in the nicotinamide adenine dinucleotide phosphate oxidase complex are associated with HCV‐related liver damage. Hepatology Communications 2017; 1(9): 973 doi: 10.1002/hep4.1103
|
| 86 |
D. L. Sulima, S. S. Suleymanova, A. A. Yakovlev, V. N. Koryagin, V. V. Rassokhin. Virological failures of primary interferon-free therapy in patients with chronic HCV RNA viremia and successful repeated interferon-free therapy. HIV Infection and Immunosuppressive Disorders 2022; 14(3): 100 doi: 10.22328/2077-9828-2022-14-3-100-109
|
| 87 |
Wey-Yil Lin, Ming-Shyan Lin, Yi-Hsin Weng, Tu-Hsueh Yeh, Yu-Sheng Lin, Po-Yu Fong, Yih-Ru Wu, Chin-Song Lu, Rou-Shayn Chen, Ying-Zu Huang. Association of Antiviral Therapy With Risk of Parkinson Disease in Patients With Chronic Hepatitis C Virus Infection. JAMA Neurology 2019; 76(9): 1019 doi: 10.1001/jamaneurol.2019.1368
|
| 88 |
Ciro Romano, Olga Tortorella, Liliana Dalla Mora, Dario Di Stasio, Ausilia Sellitto, Luigi Elio Adinolfi, Aldo Marrone. Prevalence and Outcome of Serum Autoantibodies in Chronic Hepatitis C Patients Undergoing Direct-Acting Antiviral Treatment. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.882064
|
| 89 |
Chun‐Zhong Lin, Rong‐Wen Ou, Yu‐Hai Hu. Lentiviral‐mediated microRNA‐26b up‐regulation inhibits proliferation and migration of hepatocellular carcinoma cells. The Kaohsiung Journal of Medical Sciences 2018; 34(10): 547 doi: 10.1016/j.kjms.2018.05.003
|
| 90 |
Petr Husa, Svatava Snopkova, Jirina Zavrelova, Filip Zlamal, Radek Svacinka, Petr Husa. Circulating microparticles in patients with chronic hepatitis C and changes during direct-acting antiviral therapy. Biomedical Papers 2021; 165(2): 146 doi: 10.5507/bp.2021.023
|
| 91 |
Vicente Soriano, Juan Berenguer. Extrahepatic comorbidities associated with hepatitis C virus in HIV-infected patients. Current Opinion in HIV and AIDS 2015; 10(5): 309 doi: 10.1097/COH.0000000000000175
|
| 92 |
KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney International Supplements 2018; 8(3): 91 doi: 10.1016/j.kisu.2018.06.001
|
| 93 |
Hu Li, Meng-Hao Huang, Jian-Dong Jiang, Zong-Gen Peng. Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy. World Journal of Gastroenterology 2018; 24(47): 5297-5311 doi: 10.3748/wjg.v24.i47.5297
|
| 94 |
Rahul Chaudhari, Sherouk Fouda, Ashik Sainu, Joseph M Pappachan. Metabolic complications of hepatitis C virus infection. World Journal of Gastroenterology 2021; 27(13): 1267-1282 doi: 10.3748/wjg.v27.i13.1267
|
| 95 |
Alsu Z. Malikova, Anastasia S. Shcherbakova, Konstantin A. Konduktorov, Anastasia S. Zemskaya, Alexandra A. Dalina, Vladimir I. Popenko, Olga G. Leonova, Alexei V. Morozov, Nikolay N. Kurochkin, Olga A. Smirnova, Sergey N. Kochetkov, Maxim V. Kozlov. Pre-Senescence Induction in Hepatoma Cells Favors Hepatitis C Virus Replication and Can Be Used in Exploring Antiviral Potential of Histone Deacetylase Inhibitors. International Journal of Molecular Sciences 2021; 22(9): 4559 doi: 10.3390/ijms22094559
|
| 96 |
Lenche Kostadinova, Carey L Shive, Donald D Anthony. Elevated Autotaxin and LPA Levels during Chronic Viral Hepatitis and Hepatocellular Carcinoma Associate with Systemic Immune Activation. Cancers 2019; 11(12): 1867 doi: 10.3390/cancers11121867
|
| 97 |
Hanan Mahmoud Fayed, Hasan Sedeek Mahmoud, Abdallah Elaiw Mohamed Ali. <p>The Utility of Retinol-Binding Protein 4 in Predicting Liver Fibrosis in Chronic Hepatitis C Patients in Response to Direct-Acting Antivirals</p>. Clinical and Experimental Gastroenterology 2020; : 53 doi: 10.2147/CEG.S229689
|
| 98 |
Tomasz Mikuła, Magdalena Suchacz, Mariusz Sapuła, Alicja Wiercińska-Drapało. Significance of Vascular Cell Adhesion Molecule-1 and Tumor Necrosis Factor-Alpha in HIV-Infected Patients. Journal of Clinical Medicine 2022; 11(3): 514 doi: 10.3390/jcm11030514
|
| 99 |
T. Vescovo, G. Refolo, G. Vitagliano, G.M. Fimia, M. Piacentini. Molecular mechanisms of hepatitis C virus–induced hepatocellular carcinoma. Clinical Microbiology and Infection 2016; 22(10): 853 doi: 10.1016/j.cmi.2016.07.019
|
| 100 |
Stephanie T. Chan, Jiyoung Lee, Mansi Narula, J.-H. James Ou, M. S. Diamond. Suppression of Host Innate Immune Response by Hepatitis C Virus via Induction of Autophagic Degradation of TRAF6. Journal of Virology 2016; 90(23): 10928 doi: 10.1128/JVI.01365-16
|
| 101 |
Albert Do, Denise A. Esserman, Supriya Krishnan, Joseph K. Lim, Tamar H. Taddei, Ronald G. Hauser, Janet P. Tate, Vincent Lo Re, Amy C. Justice. Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals. Journal of General Internal Medicine 2020; 35(7): 2025 doi: 10.1007/s11606-020-05782-6
|
| 102 |
Georg Peschel, Jonathan Grimm, Christa Buechler, Manuela Gunckel, Kirstin Pollinger, Elisabeth Aschenbrenner, Sylvia Kammerer, Ernst-Michael Jung, Michael Haimerl, Jens Werner, Martina Müller, Kilian Weigand. Liver stiffness assessed by shear-wave elastography declines in parallel with immunoregulatory proteins in patients with chronic HCV infection during DAA therapy. Clinical Hemorheology and Microcirculation 2021; 79(4): 541 doi: 10.3233/CH-211193
|
| 103 |
Fabrizio Fabrizi, Francesca M. Donato, Piergiorgio Messa. Hepatitis C and Its Metabolic Complications in Kidney Disease. Annals of Hepatology 2017; 16(6): 851 doi: 10.5604/01.3001.0010.5275
|
| 104 |
Lisa I. Backus, Pamela S. Belperio, Troy A. Shahoumian, Larry A. Mole. Direct‐acting antiviral sustained virologic response: Impact on mortality in patients without advanced liver disease. Hepatology 2018; 68(3): 827 doi: 10.1002/hep.29811
|
| 105 |
Ahmed Hussein, Mohamed Abdel Ghany, Hossam Eldin M. Mahmoud. Short- and long-term outcomes following percutaneous coronary intervention in hepatitis C virus seropositive patients. The Egyptian Heart Journal 2020; 72(1) doi: 10.1186/s43044-020-00079-9
|
| 106 |
Elena Grossini, Carlo Smirne, Sakthipriyan Venkatesan, Stelvio Tonello, Davide D’Onghia, Rosalba Minisini, Vincenzo Cantaluppi, Pier Paolo Sainaghi, Cristoforo Comi, Adele Tanzi, Benedetta Bussolati, Mario Pirisi. Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells. International Journal of Molecular Sciences 2023; 24(12): 10197 doi: 10.3390/ijms241210197
|
| 107 |
Peng Zhou, Gang Huang, Yuanyin Zhao, Dan Zhong, Zhizhen Xu, Yijun Zeng, Yan Zhang, Song Li, Fengtian He. MicroRNA-363-mediated downregulation of S1PR1 suppresses the proliferation of hepatocellular carcinoma cells. Cellular Signalling 2014; 26(6): 1347 doi: 10.1016/j.cellsig.2014.02.020
|
| 108 |
Shilu Mathew, Muhammed Faheem, Sara M Ibrahim, Waqas Iqbal, Bisma Rauff, Kaneez Fatima, Ishtiaq Qadri. Hepatitis C virus and neurological damage. World Journal of Hepatology 2016; 8(12): 545-556 doi: 10.4254/wjh.v8.i12.545
|
| 109 |
Shuangjin Yu, Chang Su, Xunrong Luo. Impact of infection on transplantation tolerance. Immunological Reviews 2019; 292(1): 243 doi: 10.1111/imr.12803
|
| 110 |
Abhinav Vepa, Joseph P. Bae, Faheem Ahmed, Manish Pareek, Kamlesh Khunti. COVID-19 and ethnicity: A novel pathophysiological role for inflammation. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2020; 14(5): 1043 doi: 10.1016/j.dsx.2020.06.056
|
| 111 |
Joana R. N. Lemos, Khemraj Hirani, Matthias von Herrath. Immunological and virological triggers of type 1 diabetes: insights and implications. Frontiers in Immunology 2024; 14 doi: 10.3389/fimmu.2023.1326711
|
| 112 |
Chun-Hsien Chen, Yung-Yu Hsieh, Wei-Ming Chen, Chien-Heng Shen, Kuo-Liang Wei, Kao-Chi Chang, Yuan-Jie Ding, Sheng-Nan Lu, Chao-Hung Hung, Te-Sheng Chang. Weight Gain and Increased Body Mass Index in Patients with Hepatitis C after Eradication Using Direct-Acting Antiviral Therapy in Taiwan. Diagnostics 2024; 14(2): 213 doi: 10.3390/diagnostics14020213
|
| 113 |
G. Oriolo, E. Egmond, Z. Mariño, M. Cavero, R. Navines, L. Zamarrenho, R. Solà, J. Pujol, N. Bargallo, X. Forns, R. Martin‐Santos. Systematic review with meta‐analysis: neuroimaging in hepatitis C chronic infection. Alimentary Pharmacology & Therapeutics 2018; 47(9): 1238 doi: 10.1111/apt.14594
|
| 114 |
Jung-Sheng Yu, Wei-Chun Chen, Chin-Kai Tseng, Chun-Kuang Lin, Yao-Chin Hsu, Yen-Hsu Chen, Jin-Ching Lee, Stephen J Polyak. Sulforaphane Suppresses Hepatitis C Virus Replication by Up-Regulating Heme Oxygenase-1 Expression through PI3K/Nrf2 Pathway. PLOS ONE 2016; 11(3): e0152236 doi: 10.1371/journal.pone.0152236
|
| 115 |
Alexis Ogdie, Wyki Gina Pang, Kimberly A Forde, Bhangle D Samir, Lakeisha Mulugeta, Kyong-Mi Chang, David E Kaplan, Valerianna K Amorosa, Jay R Kostman, Rajender K Reddy, Ralph H Schumacher, Vincent Lo Re. Prevalence and risk factors for patient-reported joint pain among patients with HIV/Hepatitis C coinfection, Hepatitis C monoinfection, and HIV monoinfection. BMC Musculoskeletal Disorders 2015; 16(1) doi: 10.1186/s12891-015-0552-z
|
| 116 |
Salvatore Petta. Hepatitis C virus and cardiovascular: A review. Journal of Advanced Research 2017; 8(2): 161 doi: 10.1016/j.jare.2016.06.001
|
| 117 |
Hyo Geun Choi, Jae Seung Soh, Jae Sung Lim, Song Yong Sim, Suk Woo Lee. Association between dementia and hepatitis B and C virus infection. Medicine 2021; 100(29): e26476 doi: 10.1097/MD.0000000000026476
|
| 118 |
Atefe Ghamar Talepoor, Mehrnoosh Doroudchi. Immunosenescence in atherosclerosis: A role for chronic viral infections. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.945016
|
| 119 |
Q.‐t. Huang, Q. Huang, M. Zhong, S.‐s. Wei, W. Luo, F. Li, Y.‐h. Yu. Chronic hepatitis C virus infection is associated with increased risk of preterm birth: a meta‐analysis of observational studies. Journal of Viral Hepatitis 2015; 22(12): 1033 doi: 10.1111/jvh.12430
|
| 120 |
Bin Tang, Gangcai Zhu, Changhan Chen, Siyuan Zheng, Yuting Pu, Yimin Xu, Huimei Huang, Gang Wang, Donghai Huang, Yong Liu, Xin Zhang. Hepatitis C Virus RNA Transcript Associates with Prognosis in Non‐human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma. The Laryngoscope 2021; 131(8): 1774 doi: 10.1002/lary.29422
|
| 121 |
Frank Xing, Luca Marsili, Daniel D. Truong. Parkinsonism in viral, paraneoplastic, and autoimmune diseases. Journal of the Neurological Sciences 2022; 433: 120014 doi: 10.1016/j.jns.2021.120014
|
| 122 |
L I Tkachenko, V V Maleev. The role of systemic inflammation in the pathogenesis of insulin resistance and metabolic syndrome in patients with chronic hepatitis C. Terapevticheskii arkhiv 2018; 90(11): 24 doi: 10.26442/terarkh201890114-31
|
| 123 |
Hila Shalom-Elazari, Hadas Zazrin-Greenspon, Hadassa Shaked, Jordan H. Chill. Global fold and backbone dynamics of the hepatitis C virus E2 glycoprotein transmembrane domain determined by NMR. Biochimica et Biophysica Acta (BBA) - Biomembranes 2014; 1838(11): 2919 doi: 10.1016/j.bbamem.2014.07.023
|
| 124 |
Caitlin A. Moran, Lauren F. Collins, Nour Beydoun, Puja K. Mehta, Yetunde Fatade, Ijeoma Isiadinso, Tené T. Lewis, Brittany Weber, Jill Goldstein, Igho Ofotokun, Arshed Quyyumi, May Y. Choi, Kehmia Titanji, Cecile D. Lahiri. Cardiovascular Implications of Immune Disorders in Women. Circulation Research 2022; 130(4): 593 doi: 10.1161/CIRCRESAHA.121.319877
|
| 125 |
Nick Nielsen, Sofie Jespersen, Julie Gaardbo, Caroline Arnbjerg, Mette Clausen, Mette Kjær, Jan Gerstoft, Vibe Ballegaard, Sisse Ostrowski, Susanne Nielsen. Impaired Platelet Aggregation and Rebalanced Hemostasis in Patients with Chronic Hepatitis C Virus Infection. International Journal of Molecular Sciences 2017; 18(5): 1016 doi: 10.3390/ijms18051016
|
| 126 |
Marc Ganz, Christopher Alessandro, Menachem Jacobs, Yehuda Gejerman, Daniel Miller, Frederick Okoye, Scott Jamieson, Andrew Winer. Exploring the Relationship Between Hepatitis C Virus Infection and Prostate Cancer Risk: A National Health and Nutrition Examination Survey Analysis. Cureus 2024; doi: 10.7759/cureus.54523
|
| 127 |
N. Y. Mapoure, M. N. Budzi, S. A. F. B. Eloumou, A. Malongue, C. Okalla, H. N. Luma, Yury E Khudyakov. Neurological manifestations in chronic hepatitis C patients receiving care in a reference hospital in sub-Saharan Africa: A cross-sectional study. PLOS ONE 2018; 13(3): e0192406 doi: 10.1371/journal.pone.0192406
|
| 128 |
Rosa Zampino, Anna Florio, Nicola Coppola, Grazia Cirillo, Margherita Macera, Aldo Marrone, Luigi Elio Adinolfi, Emanuele Miraglia del Giudice. PNPLA3 I148M variant as a risk factor for carotid atherosclerosis in chronic hepatitis C. International Journal of Cardiology 2014; 172(1): 291 doi: 10.1016/j.ijcard.2013.12.231
|
| 129 |
Qingsong Xu, Meisi Liu, Qishun Liu, Wenxia Wang, Yuguang Du, Heng Yin. The inhibition of LPS-induced inflammation in RAW264.7 macrophages via the PI3K/Akt pathway by highly N-acetylated chitooligosaccharide. Carbohydrate Polymers 2017; 174: 1138 doi: 10.1016/j.carbpol.2017.07.051
|
| 130 |
Faheem Ahmed, In Suk Kang, Kyung Hwan Kim, Arun Asif, Chethikkattuveli Salih Abdul Rahim, Anupama Samantasinghar, Fida Hussain Memon, Kyung Hyun Choi. Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening‐based approaches. Journal of Medical Virology 2023; 95(4) doi: 10.1002/jmv.28693
|
| 131 |
Wesal Elgretli, Tianyan Chen, Nadine Kronfli, Giada Sebastiani. Hepatitis C Virus-Lipid Interplay: Pathogenesis and Clinical Impact. Biomedicines 2023; 11(2): 271 doi: 10.3390/biomedicines11020271
|
| 132 |
Sherief Abd-Elsalam, Yousry Esam-Eldin Abo-Amer, Mohamed El-Abgeegy, Samah A. Elshweikh, Heba Fadl Elsergany, Rehab Ahmed, Mahmoud Elkadeem, Nehad Hawash, Shaimaa Soliman, Rehab Badawi, Ayman Mohammed Abdou Elguindy, Moataz Yousry Soliman, Ahmed Abdelhaleem Mohmed, Loai Mansour. Efficacy and safety of ombitasvir/paritaprevir/ritonavir/ribavirin in management of Egyptian chronic hepatitis C virus patients with chronic kidney disease. Medicine 2020; 99(42): e21972 doi: 10.1097/MD.0000000000021972
|
| 133 |
Roger Bedimo, Naim M. Maalouf, Vincent Lo Re. Hepatitis C virus coinfection as a risk factor for osteoporosis and fracture. Current Opinion in HIV and AIDS 2016; 11(3): 285 doi: 10.1097/COH.0000000000000259
|
| 134 |
Yuwei Zhang, Mohamed El-Far, Franck P. Dupuy, Mohamed S. Abdel-Hakeem, Zhong He, Francesco Andrea Procopio, Yu Shi, Elias K. Haddad, Petronela Ancuta, Rafick-Pierre Sekaly, Elias A. Said. HCV RNA Activates APCs via TLR7/TLR8 While Virus Selectively Stimulates Macrophages Without Inducing Antiviral Responses. Scientific Reports 2016; 6(1) doi: 10.1038/srep29447
|
| 135 |
Giovanni Targher, Christopher D. Byrne. Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease. Nature Reviews Nephrology 2017; 13(5): 297 doi: 10.1038/nrneph.2017.16
|
| 136 |
Alessia Gallo, Monica Miele, Ester Badami, Pier Giulio Conaldi. Molecular and cellular interplay in virus-induced tumors in solid organ recipients. Cellular Immunology 2019; 343: 103770 doi: 10.1016/j.cellimm.2018.02.010
|
| 137 |
Vasiliki Katsi, Ioannis Felekos, Stamatios Skevofilax, Constantina Aggeli, Dimitris Tousoulis, Christodoulos Stefanadis, Ioannis Kallikazaros. Cardiovascular Disease and Hepatitis C Virus Infection. Cardiology in Review 2015; 23(1): 11 doi: 10.1097/CRD.0000000000000031
|
| 138 |
T. Revuelto Artigas, N. Zaragoza Velasco, X. Gómez Arbones, T. Vidal Ballester, C. Piñol Felis, J.M. Reñe Espinet, A. Betriu Bars. Infección crónica por el virus de la hepatitis C: un factor de riesgo independiente para la ateromatosis subclínica. Revista Clínica Española 2019; 219(6): 293 doi: 10.1016/j.rce.2018.12.007
|
| 139 |
Jyoti Barokar, Allen McCutchan, Reena Deutsch, Bin Tang, Mariana Cherner, Ajay R. Bharti. Neurocognitive impairment is worse in HIV/HCV-coinfected individuals with liver dysfunction. Journal of NeuroVirology 2019; 25(6): 792 doi: 10.1007/s13365-019-00767-6
|
| 140 |
Dario Di Stasio, Alberta Lucchese, Antonio Romano, Luigi Elio Adinolfi, Rosario Serpico, Aldo Marrone. The clinical impact of direct-acting antiviral treatment on patients affected by hepatitis C virus-related oral lichen planus: a cohort study. Clinical Oral Investigations 2022; 26(8): 5409 doi: 10.1007/s00784-022-04507-9
|
| 141 |
Vincent Soriano, Pablo Labarga, José V Fernandez-Montero, Carmen de Mendoza, Isabella Esposito, Laura Benítez-Gutiérrez, Pablo Barreiro. Hepatitis C Cure with Antiviral Therapy – Benefits beyond the Liver. Antiviral Therapy 2016; 21(1): 1 doi: 10.3851/IMP2975
|
| 142 |
Chih-Wen Wang, Chung-Feng Huang, Ming-Lun Yeh, Szu-Chia Chen, Chih-Hsing Hung, Chao-Hung Kuo, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming Lung-Yu. Hepatitis C virus infection associated with coronary and thoracic aortic atherosclerosis. The American Journal of the Medical Sciences 2024; doi: 10.1016/j.amjms.2024.02.004
|
| 143 |
Yosuke Hashimoto, Minoru Tada, Manami Iida, Shotaro Nagase, Tomoyuki Hata, Akihiro Watari, Yoshiaki Okada, Takefumi Doi, Masayoshi Fukasawa, Kiyohito Yagi, Masuo Kondoh. Generation and characterization of a human–mouse chimeric antibody against the extracellular domain of claudin-1 for cancer therapy using a mouse model. Biochemical and Biophysical Research Communications 2016; 477(1): 91 doi: 10.1016/j.bbrc.2016.06.025
|
| 144 |
Waleed M. Elguindy, Waleed M. Serag. Cardiac echoparameters (geometry and dimensions), interleukin 6, and anthropometric measurements in Egyptian adolescents with hepatitis C and hepatocellular carcinoma. Egyptian Liver Journal 2017; 7(3 and 4): 58 doi: 10.1097/01.ELX.0000526967.41371.51
|
| 145 |
Danijel Galun, Dragan Basaric, Marinko Zuvela, Predrag Bulajic, Aleksandar Bogdanovic, Nemanja Bidzic, Miroslav Milicevic. Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols. World Journal of Hepatology 2015; 7(20): 2274-2291 doi: 10.4254/wjh.v7.i20.2274
|
| 146 |
Bisma Rauff, Mark W Douglas. Role of fibrogenic and inflammatory cytokines in HCV-induced fibrosis. Future Virology 2015; 10(12): 1307 doi: 10.2217/fvl.15.102
|
| 147 |
Arnolfo Petruzziello. Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma. The Open Virology Journal 2018; 12(1): 26 doi: 10.2174/1874357901812010026
|
| 148 |
Riccardo NEVOLA, Carlo ACIERNO, Pia C. PAFUNDI, Luigi E. ADINOLFI. Chronic hepatitis C infection induces cardiovascular disease and type 2 diabetes: mechanisms and management. Minerva Medica 2021; 112(2) doi: 10.23736/S0026-4806.20.07129-3
|
| 149 |
Wei-Chun Chen, Chin-Kai Tseng, Yen-Hsu Chen, Chun-Kuang Lin, Shih-hsien Hsu, Shen-Nien Wang, Jin-Ching Lee, Stephen J Polyak. HCV NS5A Up-Regulates COX-2 Expression via IL-8-Mediated Activation of the ERK/JNK MAPK Pathway. PLOS ONE 2015; 10(7): e0133264 doi: 10.1371/journal.pone.0133264
|
| 150 |
Roger Bedimo, James Cutrell, Song Zhang, Henning Drechsler, Ang Gao, Geri Brown, Irfan Farukhi, Rosinda Castanon, Pablo Tebas, Naim M. Maalouf. Mechanisms of bone disease in HIV and hepatitis C virus. AIDS 2016; 30(4): 601 doi: 10.1097/QAD.0000000000000952
|
| 151 |
Mina Nakagawa, Yasuhiro Asahina, Sei Kakinuma, Ryuichi Okamoto. Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR. Journal of Gastroenterology 2023; 58(4): 299 doi: 10.1007/s00535-022-01940-1
|
| 152 |
Nahum Méndez-Sánchez, Carlos E. Coronel-Castillo, Mariana Michelle Ramírez-Mejía. Chronic Hepatitis C Virus Infection, Extrahepatic Disease and the Impact of New Direct-Acting Antivirals. Pathogens 2024; 13(4): 339 doi: 10.3390/pathogens13040339
|
| 153 |
Elham A. Hassan, Abeer S. Abd El-Rehim, Gehan S. Seifeldein, Ghaydaa A. Shehata. Minimal hepatic encephalopathy in patients with liver cirrhosis: Magnetic resonance spectroscopic brain findings versus neuropsychological changes. Arab Journal of Gastroenterology 2014; 15(3-4): 108 doi: 10.1016/j.ajg.2014.09.003
|
| 154 |
Moema S. Santana, Rute Lopes, Isabela H. Peron, Carla R. Cruz, Ana M.M. Gaspar, Paulo I. Costa. Natural Bioactive Compounds as Adjuvant Therapy for Hepatitis C Infection. Current Nutrition & Food Science 2021; 17(5): 458 doi: 10.2174/1573401316999201009152726
|